Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus cream 1% for pruritus in pediatric atopic dermatitis
NCT00510003Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD) (2 arms), sponsored by Novartis. Primary endpoint: Change in pruritus Visual Analogic Scale. Started Dec 2004; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00510003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510003.